NEOG - Neogen Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
58.00
-0.61 (-1.04%)
As of 12:50PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close58.61
Open58.43
Bid57.88 x 1300
Ask57.99 x 800
Day's Range57.73 - 58.45
52 Week Range50.60 - 97.38
Volume41,745
Avg. Volume202,737
Market Cap3.023B
Beta (3Y Monthly)1.03
PE Ratio (TTM)49.15
EPS (TTM)1.18
Earnings DateJul 15, 2019 - Jul 19, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est63.50
Trade prices are not sourced from all markets
  • Markityesterday

    See what the IHS Markit Score report has to say about Neogen Corp.

    Neogen Corp NASDAQ/NGS:NEOGView full report here! Summary * Bearish sentiment is moderate and increasing Bearish sentimentShort interest | NeutralShort interest is moderate for NEOG with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on May 1. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.39 billion over the last one-month into ETFs that hold NEOG are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Should You Be Worried About Insider Transactions At Neogen Corporation (NASDAQ:NEOG)?
    Simply Wall St.22 days ago

    Should You Be Worried About Insider Transactions At Neogen Corporation (NASDAQ:NEOG)?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We've lost count of how many times insiders have accumulated shares in a company that goes on to improve...

  • Here’s What Hedge Funds Think About Neogen Corporation (NEOG)
    Insider Monkey26 days ago

    Here’s What Hedge Funds Think About Neogen Corporation (NEOG)

    Does Neogen Corporation (NASDAQ:NEOG) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend to […]

  • Why Is Neogen (NEOG) Up 4.2% Since Last Earnings Report?
    Zacks27 days ago

    Why Is Neogen (NEOG) Up 4.2% Since Last Earnings Report?

    Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • A Note On Neogen Corporation's (NASDAQ:NEOG) ROE and Debt To Equity
    Simply Wall St.last month

    A Note On Neogen Corporation's (NASDAQ:NEOG) ROE and Debt To Equity

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). To keep the lesson grounded in practicality, we...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of NEOG earnings conference call or presentation 26-Mar-19 3:00pm GMT

    Q3 2019 Neogen Corp Earnings Call

  • Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3
    Zacks2 months ago

    Neogen (NEOG) Earnings and Revenues Miss Estimates in Q3

    Continued weakness in the global animal protein market and strongly negative currency conversions posed as headwinds for Neogen (NEOG) in third-quarter fiscal 2019.

  • TheStreet.com2 months ago

    Neogen Tumbles as Fiscal Third-Quarter Earnings Decline

    tumbled Tuesday after the food-safety and animal sciences company released disappointing quarterly earnings. The Lansing, Michigan-based company was trading down 9.1% to $55.06 as both net earnings for the fiscal third quarter and earnings per share slid. "The quarterly results we are reporting today reflect a number of challenges in the quarter, including continued weakness in the global animal protein market and currency translation headwinds," said John Adent, Neogen's president and chief executive, in a press statement.

  • Associated Press2 months ago

    Neogen: Fiscal 3Q Earnings Snapshot

    The Lansing, Michigan-based company said it had profit of 25 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...

  • PR Newswire2 months ago

    Neogen reports third quarter results

    LANSING, Mich. , March 26, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that its revenues for the third quarter of its 2019 fiscal year, which ended Feb. 28 , were $97,700,000 ...

  • PR Newswire2 months ago

    Neogen launches coconut food allergen test kits

    LANSING, Mich. , March 25, 2019 /PRNewswire/ -- Neogen's comprehensive line of tests to detect allergens in food products before they can reach consumers now includes simple and accurate tests for coconut ...

  • Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline
    Zacks2 months ago

    Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline

    Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Neogen Corporation (NASDAQ:NEOG) Potentially Undervalued?
    Simply Wall St.3 months ago

    Is Neogen Corporation (NASDAQ:NEOG) Potentially Undervalued?

    Neogen Corporation (NASDAQ:NEOG), which is in the medical equipment business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple ofRead More...

  • Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
    Zacks3 months ago

    Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

    Sector ETF report for PSCH

  • GlobeNewswire3 months ago

    New Research Coverage Highlights Medtronic, Hewlett Packard Enterprise, World Wrestling Entertainment, Neogen, Holly Energy Partners, and Drive Shack — Consolidated Revenues, Company Growth, and Expectations for 2019

    NEW YORK, Feb. 11, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • Despite Its High P/E Ratio, Is Neogen Corporation (NASDAQ:NEOG) Still Undervalued?
    Simply Wall St.4 months ago

    Despite Its High P/E Ratio, Is Neogen Corporation (NASDAQ:NEOG) Still Undervalued?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The goal of this article is to Read More...

  • PR Newswire4 months ago

    Adent completes transition as Neogen's CEO

    LANSING, Mich., Jan. 29, 2019 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that its transition of the responsibilities from James Herbert to John Adent as the company's chief executive officer is now complete. Herbert will continue to serve as chairman of Neogen's Board of Directors, and as the company's director of strategic growth under the direction of Adent. Neogen named Adent to succeed Herbert as its CEO in July 2017.

  • Neogen Gains on Strong Genomic Arm Amid Stiff Competition
    Zacks4 months ago

    Neogen Gains on Strong Genomic Arm Amid Stiff Competition

    Neogen's (NEOG) genomic business shows steady growth on acquisitions in Australia and Brazil. Stiff rivalry a cause of concern.

  • Why Is Neogen (NEOG) Up 9.4% Since Last Earnings Report?
    Zacks4 months ago

    Why Is Neogen (NEOG) Up 9.4% Since Last Earnings Report?

    Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.